Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Breast Neoplasms 3Desmoid Tumors 2Prostatic Neoplasms 1Prostatic Intraepithelial Neoplasia 1Ovarian Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

nirogacestat 4Toremifene 2Specimen Handling 2Magnetic Resonance Spectroscopy 2X-Rays 1Vinblastine 1Taxes 1Tamoxifen 1Sunitinib 1Sulindac 1Radiotherapy 1Phantoms, Imaging 1Nivolumab 1Methotrexate 1Ipilimumab 1Imatinib Mesylate 1Hydroxyurea 1Cryosurgery 1CTLA-4 Antigen 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Desmoid Tumors × Toremifene × Clear all
NCT02353429 2015-02-02

Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
25 enrolled
Sarcoma

Desmoid Tumors

NCT00002595 2013-07-10

Toremifene in Treating Patients With Desmoid Tumors

National Cancer Institute (NCI)

Phase 2 Completed
72 enrolled
Sarcoma

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡